Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Integrative Biology

Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance

Abstract

Objective:

Lipopolysaccharide-binding protein (LBP) is a 65-kDa acute-phase protein present in blood at high concentrations, known to be derived from the liver. We aimed to gain insights into the association of circulating LBP with insulin resistance in humans and mice.

Methods, design and measurements:

We studied the cross-sectional (n=222) and weight loss-induced (n=34) associations of LBP (enzyme-linked immunosorbent assay) with inflammatory and metabolic parameters (including minimal model-measured insulin sensitivity), and the effects of high-fat diet (HFD), metformin and genetic insulin sensitization (glucagon-like peptide 1 receptor knockout model) in mice.

Results:

Circulating LBP concentration was significantly increased in subjects with type 2 diabetes and dramatically increased in subjects with morbid obesity. LBP was significantly associated with insulin sensitivity and different inflammatory markers and decreased after weight loss (22.2±5.8 vs 16.2±9.3 μg ml−1, P<0.0001) in association with changes in body mass index and insulin sensitivity. Circulating LBP concentration was increased in HFD mice, whereas decreased in glucagon-like peptide 1 receptor knockout mice (significantly more insulin sensitive than wild-type mice) and after metformin administration.

Conclusion:

LBP is an inflammatory marker associated with obesity-related insulin resistance.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808.

    Article  CAS  Google Scholar 

  2. Pickup JC, Crook MA . Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241–1248.

    Article  CAS  Google Scholar 

  3. Festa A, D’Agostino Jr R, Howard G, Mykkänen L, Tracy RP, Haffner SM . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–47.

    Article  CAS  Google Scholar 

  4. Ridker PM, Buring JE, Cook NR, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107: 391–397.

    Article  Google Scholar 

  5. Fernandez-Real JM, Ricart W . Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278–301.

    Article  CAS  Google Scholar 

  6. Lee JY, Hwang DH . The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cell 2006; 21: 174–185.

    CAS  Google Scholar 

  7. Song MJ, Kim KH, Yoon JM, Kim JB . Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006; 346: 739–745.

    Article  CAS  Google Scholar 

  8. Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W . Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006; 29: 1058–1064.

    Article  Google Scholar 

  9. Ceriello A, Motz E . Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816–823.

    Article  CAS  Google Scholar 

  10. Grube BJ, Cochane CG, Ye RD, Green CE, McPhail ME, Ulevitch RJ et al. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem 1994; 269: 8477–8482.

    CAS  PubMed  Google Scholar 

  11. Tobias PS, Soldau K, Ulevitch RJ . Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989; 264: 10867–10871.

    CAS  PubMed  Google Scholar 

  12. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994; 179: 269–277.

    Article  CAS  Google Scholar 

  13. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD . Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025–1035.

    Article  CAS  Google Scholar 

  14. Gubern C, Lopez-Bermejo A, Biarnes J, Vendrell J, Ricart W, Fernandez-Real JM . Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 2006; 55: 216–224.

    Article  CAS  Google Scholar 

  15. Lepper PM, Schumann C, Triantafilou K, Rasche FM, Schuster T, Frank H et al. Association of lipopolysaccharide-binding protein and coronary artery disease in men. J Am Coll Cardiol 2007; 50: 25–31.

    Article  CAS  Google Scholar 

  16. Sun L, Yu Z, Ye X, Zou S, Li H, Yu D et al. A marker of endotoxemia is associated with obesity and related disorders in apparently healthy Chinese. Diabetes Care 2010; 33: 1925–1932.

    Article  CAS  Google Scholar 

  17. Bergman RN, Prager R, Volund A, Olefsky JM . Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 1987; 79: 790–800.

    Article  CAS  Google Scholar 

  18. Moreno-Navarrete JM, Martínez-Barricarte R, Catalán V, Sabater M, Gómez-Ambrosi J, Ortega FJ et al. Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes 2010; 59: 200–209.

    Article  CAS  Google Scholar 

  19. Gómez-Ambrosi J, Catalán V, Ramírez B, Rodríguez A, Colina I, Silva C et al. Plasma osteopontin levels and expresión in adipose tissue in obesity. J Clin Endocrinol Metab 2007; 92: 3719–3727.

    Article  Google Scholar 

  20. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761–1772.

    Article  CAS  Google Scholar 

  21. Cabou C, Campistron G, Marsollier N, Leloup C, Cruciani-Guglielmacci C, Pénicaud L et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008; 57: 2577–2587.

    Article  CAS  Google Scholar 

  22. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470–1481.

    Article  CAS  Google Scholar 

  23. Zweigner J, Schumann RR, Weber JR . The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect 2006; 8: 946–952.

    Article  CAS  Google Scholar 

  24. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR . High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800–3808.

    Article  CAS  Google Scholar 

  25. Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R et al. Benefitial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 2011; 110: 650–657.

    Article  CAS  Google Scholar 

  26. Fernández-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998; 47: 1757–1762.

    Article  Google Scholar 

  27. Ouellet V, Weisnagel SJ, Marois J, Bergeron J, Julien P, Gougeon R et al. Dietary cod protein reduces plasma C-reactive protein in insulin-resistant men and women. J Nutr 2008; 138: 2386–2391.

    Article  CAS  Google Scholar 

  28. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010; 33: 1629–1634.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was partially supported by research grants from the Ministerio de Educación y Ciencia (SAF2008-02073) and from the FLORINASH project. CIBEROBN Fisiopatología de la Obesidad y Nutrición is an initiative from the Instituto de Salud Carlos III from Spain. We acknowledge the clinical help of Oscar Rovira.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J M Fernández-Real.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno-Navarrete, J., Ortega, F., Serino, M. et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes 36, 1442–1449 (2012). https://doi.org/10.1038/ijo.2011.256

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2011.256

Keywords

This article is cited by

Search

Quick links